GlassScriptPhysician profile
Brant A Putnam
NPI 1457407934
$8,056.16
in general payments reported to CMS, 2019-2025
29 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.33 · 2020: $329 · 2021: $235 · 2022: $233 · 2023: $85.96 · 2024: $6,775 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,665 · Food and Beverage: $798 · Travel and Lodging: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,665.03 |
| Food and Beverage | $797.53 |
| Travel and Lodging | $743.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,671.93 | 2024 | |
| Integra Lifesciences Corporation | $197.35 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $123.97 | 2021-2022 | |
| Z-Medica, LLC | $120.42 | 2019-2020 | |
| Teleflex LLC | $108.34 | 2021-2022 | |
| Vioptix INC | $84.69 | 2025 | |
| Ceribell, INC. | $77.27 | 2021-2022 | |
| Clr Medical, INC. | $75.00 | 2025 | Irrigator |
| Prytime Medical Devices, INC. | $74.83 | 2025 | Er-Reboa Plus |
| Getinge USA Sales, LLC | $56.55 | 2023 | Cardiohelp |
| Stryker Corporation | $50.77 | 2020 | |
| Ethicon US, LLC | $49.91 | 2019-2020 | |
| Allergan, INC. | $33.68 | 2020 | |
| Solventum Corporation | $32.55 | 2025 | V.A.C. Granufoam, Prevena, Abthera Advance |
| Medivance, INC. | $29.77 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $29.41 | 2024 | Andexxa |
| Activ Surgical, INC. | $27.20 | 2022 | |
| Kls-Martin L.P. | $26.90 | 2020 | |
| Alexion Pharmaceuticals, INC. | $25.10 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $20.69 | 2021 | |
| Boston Scientific Corporation | $19.33 | 2022 | |
| Medtronic, INC. | $19.17 | 2021 | |
| Tela Bio, INC. | $19.03 | 2024 | Ovitex 2s |
| Acell, INC. | $18.75 | 2019 | |
| Irras USA, INC. | $18.75 | 2021 | |
| Smith+Nephew, INC. | $17.06 | 2024 | Pico |
| W. L. Gore & Associates, INC. | $14.04 | 2022 | |
| Kci USA, INC. | $13.70 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brant Putnam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.